Literature DB >> 22704728

What do we really know about antimuscarinic therapy for adult neurogenic detrusor overactivity?

Christopher R Chapple.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22704728     DOI： 10.1016/j.eururo.2012.05.069

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

1.  Long-term use of solifenacin in pediatric patients with overactive bladder: Extension of a prospective open-label study.

Authors:  Geneviève Nadeau; Annette Schröder; Katherine Moore; Lucie Genois; Pascale Lamontagne; Micheline Hamel; Eve Pellerin; Stéphane Bolduc
Journal:  Can Urol Assoc J       Date:  2014-03       Impact factor: 1.862

2.  Antimuscarinics for neurogenic overactive bladder in multiple sclerosis: real-life data.

Authors:  Elena Andretta; Enrico Finazzi Agrò; Massimiliano Calabrese; Luca Orecchia; Antonietta Furlan; Cristina Zuliani
Journal:  Ther Adv Urol       Date:  2022-09-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.